Year All20262025202420232022 November 12, 2024 Ceribell Reports Third Quarter 2024 Financial Results November 11, 2024 Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs November 7, 2024 Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum October 29, 2024 Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 October 16, 2024 New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG October 15, 2024 CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares October 10, 2024 CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering July 22, 2024 Ceribell Announces Publication of Study Demonstrating Significant Reduction in Length of ICU Stays and Better Patient Outcomes with Ceribell Point-of-Care EEG Compared to Conventional EEG April 2, 2024 Ceribell Appoints Sean Manni as Senior Vice President of Sales January 4, 2024 Ceribell to Present at the 42nd Annual J.P. Morgan Healthcare Conference
November 11, 2024 Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs
November 7, 2024 Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
October 16, 2024 New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG
October 15, 2024 CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
July 22, 2024 Ceribell Announces Publication of Study Demonstrating Significant Reduction in Length of ICU Stays and Better Patient Outcomes with Ceribell Point-of-Care EEG Compared to Conventional EEG
